Inflammation Research Unit, Pfizer Global Research and Development, Pfizer Inc., St. Louis, MO, USA.
FEBS Lett. 2010 Jul 2;584(13):2827-32. doi: 10.1016/j.febslet.2010.04.064. Epub 2010 Apr 29.
Lysophosphatidic acid (LPA), an inflammatory mediator that is elevated in multiple inflammatory diseases, is a potent activator of Rho kinase (ROCK) signaling and of chemokine production in endothelial cells. In this study, LPA activated ROCK, p38, JNK and NF-kappaB pathways and induced interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) mRNA and protein expression in human endothelial cells. We mapped signaling events downstream of ROCK, driving chemokine production. In summary, MCP-1 production was partly regulated by ROCK acting upstream of p38 and JNK and mediated downstream by NF-kappaB. IL-8 production was largely driven by ROCK through p38 and JNK activation, but with no involvement of NF-kappaB.
溶血磷脂酸(LPA)是一种在多种炎症性疾病中升高的炎症介质,是 Rho 激酶(ROCK)信号和内皮细胞中趋化因子产生的有效激活剂。在这项研究中,LPA 激活了 ROCK、p38、JNK 和 NF-κB 途径,并诱导人内皮细胞中白细胞介素 8(IL-8)和单核细胞趋化蛋白 1(MCP-1)mRNA 和蛋白的表达。我们绘制了 ROCK 下游的信号事件图谱,这些事件驱动趋化因子的产生。综上所述,MCP-1 的产生部分受到 ROCK 的调节,ROCK 在上游作用于 p38 和 JNK,下游通过 NF-κB 介导。IL-8 的产生主要由 ROCK 通过 p38 和 JNK 的激活驱动,但 NF-κB 不参与。